Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial.
Nov 2011 - J Transl Med; 9:1479-5876 [PMID:22013914]
[Baek S] [Kim CS] [Kim SB] [Kim YM] [Kwon SW] [Kim Y] [Kim H] [Lee H]

Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma.
Apr 2007 - Cancer Immunol. Immunother.; 56(7):0340-7004 [PMID:17131118]
[Yasuda T] [Kamigaki T] [Kawasaki K] [Nakamura T] [Yamamoto M] [Kanemitsu K] [Takase S] [Kuroda D] [Kim Y] [Ajiki T] [Kuroda Y]